FABP4 and type 2 diabetes mellitus: Clinical studies point out that serum FABP4 is positively associated with the degree of abdominal aortic calcification in peritoneal dialysis patients [30] as well as with the presence of coronary artery calcium in patients with type-2 diabetes mellitus [31].